You are here

  • Home
  • Archive
  • Volume 7, Issue 1
  • Calreticulin exposure correlates with robust adaptive antitumor immunity and favorable prognosis in ovarian carcinoma patients

Article info

Article menu

Download PDFPDF

XML
Research Article
Calreticulin exposure correlates with robust adaptive antitumor immunity and favorable prognosis in ovarian carcinoma patients

Authors

  • Lenka Kasikova Department of ImmunologyCharles University, 2nd Faculty of Medicine and University Hospital Motol V Uvalu 84 150 00 Prague 5 Czech Republic Sotio Prague Czech Republic PubMed articlesGoogle scholar articles
  • Michal Hensler Sotio Prague Czech Republic PubMed articlesGoogle scholar articles
  • Iva Truxova Department of ImmunologyCharles University, 2nd Faculty of Medicine and University Hospital Motol V Uvalu 84 150 00 Prague 5 Czech Republic Sotio Prague Czech Republic PubMed articlesGoogle scholar articles
  • Petr Skapa Department of Pathology and Molecular MedicineCharles University, 2nd Faculty of Medicine and University Hospital Motol Prague Czech Republic PubMed articlesGoogle scholar articles
  • Jan Laco The Fingerland Department of PathologyCharles University, Faculty of Medicine and University Hospital Hradec Kralove Czech Republic PubMed articlesGoogle scholar articles
  • Lucie Belicova Sotio Prague Czech Republic PubMed articlesGoogle scholar articles
  • Ivan Praznovec Department of Gynecology and ObstetricsCharles University, Faculty of Medicine and University Hospital Hradec Kralove Czech Republic PubMed articlesGoogle scholar articles
  • Sarka Vosahlikova Sotio Prague Czech Republic PubMed articlesGoogle scholar articles
  • Michael J. Halaska Department of Gynecology and ObstetricsCharles University, 3rd Faculty of Medicine and University Hospital Kralovske Vinohrady Prague Czech Republic PubMed articlesGoogle scholar articles
  • Tomas Brtnicky Department of Gynecology and ObstetricsCharles University, 2nd Faculty of Medicine and University Hospital Motol Prague Czech Republic PubMed articlesGoogle scholar articles
  • Lukas Rob Department of Gynecology and ObstetricsCharles University, 3rd Faculty of Medicine and University Hospital Kralovske Vinohrady Prague Czech Republic PubMed articlesGoogle scholar articles
  • Jiri Presl Department of Gynecology and ObstetricsFaculty of Medicine and University Hospital Plzen Pilsen Czech Republic PubMed articlesGoogle scholar articles
  • Jan Kostun Department of Gynecology and ObstetricsFaculty of Medicine and University Hospital Plzen Pilsen Czech Republic PubMed articlesGoogle scholar articles
  • Isabelle Cremer Inflammation, Complement and Cancer, INSERM, U1138, Centre de Recherche des Cordeliers Paris France Sorbonne Université Paris France Université Paris Descartes, Paris, France Paris France PubMed articlesGoogle scholar articles
  • Ales Ryska The Fingerland Department of PathologyCharles University, Faculty of Medicine and University Hospital Hradec Kralove Czech Republic PubMed articlesGoogle scholar articles
  • Guido Kroemer Université Paris Descartes, Paris, France Paris France Metabolomics and Cell Biology PlatformsInstitut Gustave Roussy Villejuif France Pôle de BiologieHôpital Européen Georges Pompidou, AP-HP Paris France Suzhou Institute for Systems BiologyChinese Academy of Sciences Suzhou China Karolinska Institute, Department of Women’s and Children’s HealthKarolinska University Hospital Stockholm Sweden PubMed articlesGoogle scholar articles
  • Lorenzo Galluzzi Université Paris Descartes, Paris, France Paris France Department of Radiation OncologyWeill Cornell Medical College New York NY USA Sandra and Edward Meyer Cancer Center New York NY USA Department of DermatologyYale School of Medicine New Haven CT USA PubMed articlesGoogle scholar articles
  • Radek Spisek Department of ImmunologyCharles University, 2nd Faculty of Medicine and University Hospital Motol V Uvalu 84 150 00 Prague 5 Czech Republic Sotio Prague Czech Republic PubMed articlesGoogle scholar articles
  • Jitka Fucikova Department of ImmunologyCharles University, 2nd Faculty of Medicine and University Hospital Motol V Uvalu 84 150 00 Prague 5 Czech Republic Sotio Prague Czech Republic PubMed articlesGoogle scholar articles
  1. ↵s fucikova{at}sotio.com
View Full Text

Citation

Kasikova L, Hensler M, Truxova I, et al
Calreticulin exposure correlates with robust adaptive antitumor immunity and favorable prognosis in ovarian carcinoma patients
Journal for ImmunoTherapy of Cancer 2019;7:312. doi: 10.1186/s40425-019-0781-z

Publication history

  • Received July 8, 2019
  • Accepted October 22, 2019
  • First published November 20, 2019.
Online issue publication 
January 08, 2022

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© The Author(s). Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.